These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


496 related items for PubMed ID: 11884620

  • 21. Epidermal growth factor receptor targeting prevents uncoupling of the Grb2-SOS complex.
    Holt KH, Waters SB, Okada S, Yamauchi K, Decker SJ, Saltiel AR, Motto DG, Koretzky GA, Pessin JE.
    J Biol Chem; 1996 Apr 05; 271(14):8300-6. PubMed ID: 8626525
    [Abstract] [Full Text] [Related]

  • 22. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
    Sasaoka T, Langlois WJ, Bai F, Rose DW, Leitner JW, Decker SJ, Saltiel A, Gill GN, Kobayashi M, Draznin B, Olefsky JM.
    J Biol Chem; 1996 Apr 05; 271(14):8338-44. PubMed ID: 8626530
    [Abstract] [Full Text] [Related]

  • 23. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation.
    Vanderkuur JA, Butch ER, Waters SB, Pessin JE, Guan KL, Carter-Su C.
    Endocrinology; 1997 Oct 05; 138(10):4301-7. PubMed ID: 9322943
    [Abstract] [Full Text] [Related]

  • 24. Phosphatidylinositol 3-kinase is required for insulin-stimulated tyrosine phosphorylation of Shc in 3T3-L1 adipocytes.
    Ugi S, Sharma PM, Ricketts W, Imamura T, Olefsky JM.
    J Biol Chem; 2002 May 24; 277(21):18592-7. PubMed ID: 11897789
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Expression of the ErbB4 receptor causes reversal regulation of PP2A in the Shc signal transduction pathway in human cancer cells.
    Yumoto N, Yu X, Hatakeyama M.
    Mol Cell Biochem; 2006 Apr 24; 285(1-2):165-71. PubMed ID: 16477370
    [Abstract] [Full Text] [Related]

  • 27. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
    Gu J, Tamura M, Yamada KM.
    J Cell Biol; 1998 Nov 30; 143(5):1375-83. PubMed ID: 9832564
    [Abstract] [Full Text] [Related]

  • 28. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.
    Walker F, Kato A, Gonez LJ, Hibbs ML, Pouliot N, Levitzki A, Burgess AW.
    Mol Cell Biol; 1998 Dec 30; 18(12):7192-204. PubMed ID: 9819406
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S, Hakuno F, Takahashi S.
    Endocr J; 2000 Dec 30; 47(6):739-51. PubMed ID: 11228049
    [Abstract] [Full Text] [Related]

  • 31. Growth factors differentially stimulate the phosphorylation of Shc proteins and their association with Grb2 in PC-12 pheochromocytoma cells.
    Ohmichi M, Matuoka K, Takenawa T, Saltiel AR.
    J Biol Chem; 1994 Jan 14; 269(2):1143-8. PubMed ID: 8288573
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation.
    Gotoh N, Toyoda M, Shibuya M.
    Mol Cell Biol; 1997 Apr 14; 17(4):1824-31. PubMed ID: 9121430
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP, Lambert QT, Der CJ.
    J Biol Chem; 1998 Aug 07; 273(32):20431-7. PubMed ID: 9685397
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc.
    Chen W, Martindale JL, Holbrook NJ, Liu Y.
    Mol Cell Biol; 1998 Sep 07; 18(9):5178-88. PubMed ID: 9710602
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.